HSCT Clinical Trials

2 recruiting

HSCT Trials at a Glance

17 actively recruiting trials for hsct are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Phase 1 with 4 trials, with the heaviest enrollment activity in Boston, Baltimore, and Beijing. Lead sponsors running hsct studies include Chinese PLA General Hospital, Children's Hospital Medical Center, Cincinnati, and Ceren Derya Gültekin.

Browse hsct trials by phase

Treatments under study

About HSCT Clinical Trials

Looking for clinical trials for HSCT? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HSCT trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HSCT clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Phase 2

Ivosidenib as Post-HSCT Maintenance for AML

Acute Myeloid Leukemia (AML)IDH1 MutationHematopoietic Stem Cell Transplant (HSCT)
Massachusetts General Hospital75 enrolled4 locationsNCT06707493
Recruiting
Phase 2

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Hematologic MalignanciesHematopoietic Stem Cell Transplant (HSCT)
Pulmotect, Inc.100 enrolled11 locationsNCT06665100
Recruiting

Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.

Liver DiseasesHematopoietic Stem Cell Transplantation (HSCT)Iron Overload+1 more
Assistance Publique - Hôpitaux de Paris500 enrolled1 locationNCT07028112
Recruiting
Not Applicable

Massage Impact on Sleep in Pediatric Oncology

CancerAcute Myeloid LeukemiaChemotherapy Effect+3 more
Children's Hospital of Philadelphia70 enrolled2 locationsNCT06892158
Recruiting

Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
National Heart, Lung, and Blood Institute (NHLBI)40 enrolled1 locationNCT06093867
Recruiting
Phase 1

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

EBV Infection After Allogenic HSCT
Chinese PLA General Hospital12 enrolled1 locationNCT06119256
Recruiting
Phase 4

Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Chinese PLA General Hospital200 enrolled1 locationNCT07101588
Recruiting
Phase 1

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

Acute Myeloid LeukemiaHSCTMDS (Myelodysplastic Syndrome)+1 more
First Affiliated Hospital of Zhejiang University130 enrolled1 locationNCT07321626
Recruiting
Phase 1

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

Viral InfectionHematopoietic Stem Cell Transplantation (HSCT)Primary Immunodeficiency Disorders (PID)
Children's National Research Institute48 enrolled3 locationsNCT04691622
Recruiting
Phase 1

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Myelodysplastic Syndrome (MDS)Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Acute Myeloid Leukaemia (AML)
medac GmbH36 enrolled4 locationsNCT05534620
Recruiting

High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)

Multiple MyelomaMyelodysplastic SyndromeLymphoma+12 more
Yigeng Cao,MD,PhD1,000 enrolled1 locationNCT07205523
Recruiting

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Hematopoietic Stem Cell Transplant (HSCT)Thrombotic MicroangiopathiesDiffuse Alveolar Hemorrhage+2 more
Children's Hospital Medical Center, Cincinnati2,000 enrolled9 locationsNCT04098445
Recruiting
Not Applicable

Effects of Different Inspiratory Muscle Training Protocols in Hematopoietic Stem Cell Transplant Recipients

Pulmonary RehabilitationInspiratory Muscle TrainingHematopoietic Stem Cell Transplantation (HSCT)
Ceren Derya Gültekin45 enrolled1 locationNCT07061444
Recruiting

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

GVHD - Graft-Versus-Host DiseaseInfections After HSCTTransplant Associated Microangiopathy TAM+2 more
University of Turin, Italy30 enrolled2 locationsNCT06715046
Recruiting

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplant (HSCT)
The University of Hong Kong1,000 enrolled2 locationsNCT06702111
Recruiting
Not Applicable

Comparison of Intralipid With SMOF Lipid Following HSCT

LeukemiaHSCT
Shahid Beheshti University50 enrolled1 locationNCT06625372
Recruiting

Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Universitaire Ziekenhuizen KU Leuven55 enrolled1 locationNCT01420562